These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 7519990
1. Prostate-specific antigen density: a means to enhance detection of prostate cancer. Ramon J, Boccon-Gibod L, Billebaud T, Astier L, Kobelinsky M, Meulemans A, Dauge MC, Boccon-Gibod L, Villers A. Eur Urol; 1994; 25(4):288-94; discussion 304. PubMed ID: 7519990 [Abstract] [Full Text] [Related]
5. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer. Yu HJ, Lai MK. Urology; 1998 May; 51(5A Suppl):125-30. PubMed ID: 9610567 [Abstract] [Full Text] [Related]
6. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K, Nomi M, Egawa S, Morisue K, Takenaka A, Okamoto M, Ohori M, Fujii A. Cancer; 1997 May 15; 79(10):1969-76. PubMed ID: 9149025 [Abstract] [Full Text] [Related]
12. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution. Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y. BJU Int; 2005 Jun 15; 95(9):1245-8. PubMed ID: 15892809 [Abstract] [Full Text] [Related]
13. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection. Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y. Int J Urol; 2005 Oct 15; 12(10):881-5. PubMed ID: 16323981 [Abstract] [Full Text] [Related]
14. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges. Meshref AW, Bazinet M, Trudel C, Aronson S, Peloquin F, Nachabe M, Dessureault J, Aprikian AG, Begin LR, Elhilali MM. Urology; 1995 Jun 15; 45(6):972-9. PubMed ID: 7539562 [Abstract] [Full Text] [Related]
15. The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml. Akdas A, Tarcan T, Türkeri L, Cevik I, Biren T, Ilker Y. Eur Urol; 1996 Jun 15; 29(2):189-92. PubMed ID: 8647145 [Abstract] [Full Text] [Related]
16. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels. Schmid HP, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L. Urology; 1996 May 15; 47(5):699-703. PubMed ID: 8650868 [Abstract] [Full Text] [Related]
17. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men. Sheikh M, Al-Saeed O, Kehinde EO, Sinan T, Anim JT, Ali Y. Int Urol Nephrol; 2005 May 15; 37(4):721-6. PubMed ID: 16362587 [Abstract] [Full Text] [Related]
18. [Examination for indication of systematic biopsy for diagnosis of prostate cancer]. Muraoka K, Takahashi C, Yamamoto Y, Watanabe T, Hirakawa S, Miyagawa I. Nihon Hinyokika Gakkai Zasshi; 1999 Jul 15; 90(7):657-62. PubMed ID: 10481471 [Abstract] [Full Text] [Related]